EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Application of bifidobacterium in tumor therapy

Yinwu Kong, Han Bai, Feifei Deng, Yaomin Zhao, Qianyan Li, Li Chang

Frontiers in Oncology · 15.05.2025 · 15

DOI: 10.3389/fonc.2025.1551924 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 15.05.2025. Verfasst von Yinwu Kong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current clinical cancer treatments primarily rely on surgery, chemotherapy, radiotherapy, and immunotherapy; however, each approach has inherent limitations. In recent years, nanomaterials have gained significant attention in oncology due to their advantages in precise drug delivery, enhanced targeting, and improved therapeutic efficacy. Nevertheless, their clinical application remains limited by challenges such as complex synthesis, high costs, low delivery efficiency, and poor biodegradability. Bifidobacterium (BBM), a clinically used probiotic, has demonstrated unique tumor-targeting potential due to its obligate anaerobic nature, allowing it to selectively colonize, proliferate, and expand within the hypoxic tumor microenvironment. Recent advancements in synthetic biology and bacterial engineering have enabled the modification of Bifidobacterium as a microrobot for molecular imaging, drug or gene delivery, and other therapeutic functions. Compared to nanomaterials, Bifidobacterium-based bacterial therapy holds promise in overcoming certain limitations while potentially enhancing comprehensive cancer treatment by modulating the tumor microenvironment and boosting host immune responses. This review summarizes the latest progress in Bifidobacterium-mediated tumor imaging and therapy, explores its mechanisms of action, engineering strategies, and clinical applications, and discusses future directions for optimizing its functional design to improve therapeutic efficacy and safety.

Schlagwörter

Stichwörter der Autor:innen

bifidobacteriumimmune activationmalignant tumorsnanomaterialstumor hypoxic microenvironmenttumor targeting

Autor:innen und Institutionen

  • Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
  • The 920th Hospital of Joint Logistics Support Force, Kunming, China.

Zitieren

APA

Kong, Y., Bai, H., Deng, F., Zhao, Y., Li, Q., & Chang, L. (2025). Application of bifidobacterium in tumor therapy. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1551924

Vancouver

Kong Y, Bai H, Deng F, Zhao Y, Li Q, Chang L. Application of bifidobacterium in tumor therapy. Frontiers in Oncology. 2025;15. doi:10.3389/fonc.2025.1551924

BibTeX
@article{Kong2025,
  author = {Kong, Yinwu and Bai, Han and Deng, Feifei and Zhao, Yaomin and Li, Qianyan and Chang, Li},
  title = {Application of bifidobacterium in tumor therapy},
  journal = {Frontiers in Oncology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fonc.2025.1551924}
}
Kostenlos starten →